東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 2,514 | 2,521 | 2,463 | 2,467 | -42 | -1.7% | 59,400 |
2021/03/22 | 2,473 | 2,523 | 2,471 | 2,509 | -14 | -0.6% | 82,200 |
2021/03/19 | 2,445 | 2,525 | 2,435 | 2,523 | +83 | +3.4% | 171,400 |
2021/03/18 | 2,450 | 2,480 | 2,428 | 2,440 | +11 | +0.5% | 107,700 |
2021/03/17 | 2,391 | 2,434 | 2,384 | 2,429 | +11 | +0.5% | 96,600 |
2021/03/16 | 2,374 | 2,418 | 2,357 | 2,418 | +66 | +2.8% | 95,400 |
2021/03/15 | 2,328 | 2,352 | 2,310 | 2,352 | +26 | +1.1% | 93,800 |
2021/03/12 | 2,338 | 2,338 | 2,300 | 2,326 | -26 | -1.1% | 79,900 |
2021/03/11 | 2,335 | 2,380 | 2,315 | 2,352 | +37 | +1.6% | 105,400 |
2021/03/10 | 2,316 | 2,336 | 2,291 | 2,315 | -1 | ±0% | 66,800 |
2021/03/09 | 2,260 | 2,325 | 2,237 | 2,316 | +77 | +3.4% | 127,800 |
2021/03/08 | 2,253 | 2,261 | 2,222 | 2,239 | -1 | ±0% | 66,500 |
2021/03/05 | 2,218 | 2,243 | 2,214 | 2,240 | +22 | +1% | 90,500 |
2021/03/04 | 2,200 | 2,218 | 2,182 | 2,218 | +19 | +0.9% | 102,400 |
2021/03/03 | 2,159 | 2,200 | 2,140 | 2,199 | +74 | +3.5% | 113,100 |
2021/03/02 | 2,160 | 2,160 | 2,101 | 2,125 | -24 | -1.1% | 114,600 |
2021/03/01 | 2,100 | 2,151 | 2,100 | 2,149 | +53 | +2.5% | 69,600 |
2021/02/26 | 2,145 | 2,165 | 2,091 | 2,096 | -49 | -2.3% | 127,800 |
2021/02/25 | 2,178 | 2,184 | 2,135 | 2,145 | +8 | +0.4% | 94,900 |
2021/02/24 | 2,222 | 2,229 | 2,133 | 2,137 | -93 | -4.2% | 171,000 |
2021/02/22 | 2,237 | 2,255 | 2,220 | 2,230 | +7 | +0.3% | 82,800 |
2021/02/19 | 2,222 | 2,231 | 2,191 | 2,223 | -19 | -0.8% | 140,500 |
2021/02/18 | 2,227 | 2,251 | 2,220 | 2,242 | +19 | +0.9% | 71,300 |
2021/02/17 | 2,242 | 2,247 | 2,205 | 2,223 | -20 | -0.9% | 83,800 |
2021/02/16 | 2,240 | 2,253 | 2,214 | 2,243 | +6 | +0.3% | 91,300 |
2021/02/15 | 2,168 | 2,267 | 2,167 | 2,237 | +114 | +5.4% | 249,000 |
2021/02/12 | 2,153 | 2,155 | 2,115 | 2,123 | -29 | -1.3% | 57,500 |
2021/02/10 | 2,123 | 2,163 | 2,111 | 2,152 | +27 | +1.3% | 64,200 |
2021/02/09 | 2,125 | 2,130 | 2,110 | 2,125 | ±0 | ±0% | 91,400 |
2021/02/08 | 2,076 | 2,133 | 2,070 | 2,125 | +49 | +2.4% | 101,700 |
2021/02/05 | 2,071 | 2,091 | 2,063 | 2,076 | -11 | -0.5% | 93,200 |
2021/02/04 | 2,035 | 2,096 | 2,020 | 2,087 | +52 | +2.6% | 69,300 |
2021/02/03 | 2,021 | 2,046 | 2,012 | 2,035 | -11 | -0.5% | 96,400 |
2021/02/02 | 2,080 | 2,091 | 2,038 | 2,046 | -37 | -1.8% | 95,100 |
2021/02/01 | 2,079 | 2,107 | 2,069 | 2,083 | -10 | -0.5% | 121,100 |
2021/01/29 | 2,050 | 2,116 | 2,037 | 2,093 | +41 | +2% | 222,000 |
2021/01/28 | 1,995 | 2,065 | 1,981 | 2,052 | +50 | +2.5% | 370,000 |
2021/01/27 | 1,980 | 2,019 | 1,976 | 2,002 | +31 | +1.6% | 126,900 |
2021/01/26 | 1,986 | 1,993 | 1,971 | 1,971 | -15 | -0.8% | 93,800 |
2021/01/25 | 1,940 | 1,990 | 1,926 | 1,986 | +65 | +3.4% | 131,200 |
2021/01/22 | 1,950 | 1,953 | 1,918 | 1,921 | -40 | -2% | 136,700 |
2021/01/21 | 1,968 | 1,993 | 1,961 | 1,961 | -11 | -0.6% | 112,300 |
2021/01/20 | 1,935 | 1,974 | 1,929 | 1,972 | +37 | +1.9% | 98,500 |
2021/01/19 | 1,935 | 1,945 | 1,910 | 1,935 | -15 | -0.8% | 78,800 |
2021/01/18 | 1,935 | 1,972 | 1,935 | 1,950 | +15 | +0.8% | 59,000 |
2021/01/15 | 1,970 | 1,970 | 1,934 | 1,935 | -39 | -2% | 73,500 |
2021/01/14 | 1,941 | 1,977 | 1,926 | 1,974 | +34 | +1.8% | 70,200 |
2021/01/13 | 1,984 | 1,985 | 1,940 | 1,940 | -58 | -2.9% | 80,200 |
2021/01/12 | 1,970 | 2,001 | 1,954 | 1,998 | +64 | +3.3% | 158,100 |
2021/01/08 | 1,901 | 1,937 | 1,901 | 1,934 | +30 | +1.6% | 79,700 |
901~
950
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム